Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4012-4018
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4012
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4012
Table 1 Baseline characteristics of the subjects between the two groups (mean ± SD)
| L. plantarum 299v (DSM 9843) (n =108) | Placebo (n =106) | P | |
| Age (yr) | 36.53 ± 12.08 | 38.40 ± 13.13 | NS |
| Men/women | 70/38 | 81/25 | NS |
| IBS duration (yr) | 3.4 | 4.6 | NS |
| Abdominal pain frequency | 2.1 ±1.01 | 1.98±0.91 | NS |
| Abdominal pain severity | 1.24 ± 0.60 | 1.20 ± 0.63 | NS |
| Bloating severity | 1.07 ± 0.62 | 1.14 ±0.64 | NS |
| Stool frequency | 3.94 ± 1.51 | 3.69 ± 1.34 | NS |
| Pure vegetarians (%) | 30.5 | 20.2 | NS |
| Daily yoghurt intake (%) | 46.7 | 42.1 | NS |
-
Citation: Ducrotté P, Sawant P, Jayanthi V. Clinical trial:
Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 2012; 18(30): 4012-4018 - URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4012.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4012